Skip to main content

Why Danaher (DHR) Stock Is Trading Up Today

DHR Cover Image

What Happened?

Shares of diversified science and technology company Danaher (NYSE: DHR) jumped 7.5% in the afternoon session after the company reported third-quarter 2025 financial results that surpassed analyst expectations for revenue and profit. Danaher announced revenue grew 4.4% from the previous year to $6.05 billion, ahead of the $6.01 billion consensus estimate. The company’s adjusted earnings per share also came in strong at $1.89, higher than the anticipated $1.72. The report was not entirely positive, however, as management's revenue guidance for the upcoming fourth quarter of $6.70 billion came in below Wall Street's expectations of $7.03 billion. Despite the weaker outlook, investors appeared to focus on the current quarter's outperformance, sending the stock higher.

Is now the time to buy Danaher? Access our full analysis report here.

What Is The Market Telling Us

Danaher’s shares are not very volatile and have only had 8 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.

The previous big move we wrote about was 20 days ago when the stock gained 6.6% on the news that its subsidiary, Leica Biosystems, announced the launch of new artificial intelligence (AI)-powered digital pathology solutions. 

The new offerings, part of the Aperio Digital Pathology portfolio, include an advanced AI-powered image management solution called Aperio HALO AP. This system is designed to accelerate the digital transformation of pathology by providing an intuitive interface for on-screen review and collaboration. The announcement highlights Danaher's ongoing innovation within its subsidiaries. This follows other positive developments, such as another Danaher company, Beckman Coulter, recently launching the first fully automated test for certain neurodegenerative diseases. These advancements in the Life Sciences and Diagnostics sectors appear to be boosting investor confidence in the company's growth prospects.

Danaher is down 2.8% since the beginning of the year, and at $223.43 per share, it is trading 17.9% below its 52-week high of $272.09 from October 2024. Investors who bought $1,000 worth of Danaher’s shares 5 years ago would now be looking at an investment worth $986.23.

Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  216.77
-5.26 (-2.37%)
AAPL  255.68
-7.09 (-2.70%)
AMD  225.14
-12.89 (-5.42%)
BAC  50.46
-1.06 (-2.06%)
GOOG  250.92
-0.42 (-0.17%)
META  724.87
-8.40 (-1.15%)
MSFT  518.14
+0.49 (0.09%)
NVDA  177.03
-4.13 (-2.28%)
ORCL  271.18
-3.97 (-1.44%)
TSLA  430.10
-12.50 (-2.82%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.